CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- 4 Grant or award Director acquired 1,193 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $79.05 ($395,250)
- 4 Open-market sale President & CEO sold 7,500 shares at an average $78.13 ($585,989)
- 4 Open-market sale Chief Commercial Officer sold 14,801 shares at an average $86.99 ($1,287,487)
- 4 Open-market sale President & CEO sold 7,500 shares at an average $74.83 ($561,196)
- 4 Exercise or conversion President & CEO acquired 193,074 shares (option exercise)
- 4 Open-market sale President & CEO sold 7,500 shares at an average $80.72 ($605,391)
- 4 Open-market sale Chief Financial Officer sold 5,000 shares at $79.51 ($397,550)
- 4 Other acquisition Director acquired 242,477 shares (other)
- 4 Open-market sale Chief Commercial Officer sold 15,000 shares at an average $80.12 ($1,201,800)
- 4 Open-market sale Director sold 3,500 shares at $80.10 ($280,350)
- 4 Open-market sale Director sold 5,934 shares at an average $76.69 ($455,100)
- 4 Open-market sale Director sold 5,000 shares at an average $78.06 ($390,315)
- 4 Open-market sale President & CEO sold 37,827 shares at an average $73.65 ($2,786,085)
- 4 Open-market sale Director sold 10,000 shares at $75.13 ($751,300)
- 4 Open-market sale Chief Commercial Officer sold 35,930 shares at an average $73.51 ($2,641,114)
- 4 Grant or award VP, Global Regulatory Affairs acquired 5,685 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 13,075 shares (grant or award)
- 4 Grant or award VP, Clinical Affairs acquired 5,685 shares (grant or award)
- 4 Grant or award Corcoran Nicholas acquired 12,886 shares (grant or award)
Page 8 of 18 · 358 filings